Marloes van Dongen
M.D., Ph.D., Licensed Medical Oncologist and Clinical Pharmacologist.
Marloes van Dongen's main scientific interests are focused on breast cancer treatment, new drug development, including the performance of clinical phase I and early phase II trials. She is part of the breast cancer team and the early phase clinical trials team. Marloes van Dongen did her PhD (2015) at the Centre for Human Drug Research Leiden on early phase trials on antisense oligonucleotides and the role of glucagon in glucose homeostasis. Besides her clinical activities, she has been chair of the young oncologists' section of the Dutch Association for Medical Oncology (2016-2018) and she is currently program chair for the Dutch Annual Breast Cancer workshop and serves as editor for the journal Medische Oncologie.
She has been principal investigator for many industry sponsored clinical trials
and advisor for several pharmaceutical companies. Furthermore, she is co-author of several handbooks for both patients and specialists.
Marloes van Dongen's main scientific interests are focused on breast cancer treatment, new drug development, including the performance of clinical phase I and early phase II trials. She is part of the breast cancer team and the early phase clinical trials team. Marloes van Dongen did her PhD (2015) at the Centre for Human Drug Research Leiden on early phase trials on antisense oligonucleotides and the role of glucagon in glucose homeostasis. Besides her clinical activities, she has been chair of the young oncologists' section of the Dutch Association for Medical Oncology (2016-2018) and she is currently program chair for the Dutch Annual Breast Cancer workshop and serves as editor for the journal Medische Oncologie.
She has been principal investigator for many industry sponsored clinical trials
and advisor for several pharmaceutical companies. Furthermore, she is co-author of several handbooks for both patients and specialists.
Specialism and interests
- Breast cancer treatment
- Early Drug Development and Clinical Trials
- Targeted Therapy
- Immunotherapy
- Personalized Medicine
Relevant committees/networks/other relevant to mention
- Editor of the Netherlands Oncology Journal
- Advisory board of various pharmaceutical companies
- Founder of the Dutch breast cancer multi-day workshop
Publications
Find a list of Marloes van Dongen's publications here